| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/09/2013 | EP2542539A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 01/09/2013 | EP2542246A1 Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
| 01/09/2013 | EP2542230A2 Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1 |
| 01/09/2013 | CN1972668B Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 01/09/2013 | CN102869776A Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF |
| 01/09/2013 | CN102869363A Lyophilized cake formulations |
| 01/09/2013 | CN102869359A Imidazopyridine compounds, compositions and methods of use |
| 01/09/2013 | CN102864152A Immunostimulation characteristic of oligonucleotide-based compound comprising modified immunostimulation dinucleotide |
| 01/09/2013 | CN102864151A Novel synthetic agonists of tlr9 |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102861340A Intelligent nano delivery system, preparation method and application thereof |
| 01/09/2013 | CN102861320A Spray for treating skin and mucosa wounds |
| 01/09/2013 | CN102861316A Stab wound and gunshot wound healing powder |
| 01/09/2013 | CN102861313A Traditional Chinese medicine composition for promoting healing of post-operation scars |
| 01/09/2013 | CN102861312A Plaster for treating osteoarthritis and phymatosis |
| 01/09/2013 | CN102861287A Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof |
| 01/09/2013 | CN102861274A External use traditional Chinese medicine for treating eczema |
| 01/09/2013 | CN102861273A Preparation method of traditional Chinese medicine wet wipes for treating exudative children eczema |
| 01/09/2013 | CN102861272A Preparation method of traditional Chinese medicine wet issue for treating urticaria papulosa |
| 01/09/2013 | CN102861271A External-use inflammation-diminishing itching-relieving ointment preparation and preparation method thereof |
| 01/09/2013 | CN102861269A Drug combination for treating acne |
| 01/09/2013 | CN102861253A Foot immersing medicament for treating dermatophytosis |
| 01/09/2013 | CN102861217A External emplastrum for treating malignant boil, sores and carbuncles |
| 01/09/2013 | CN102861216A Compound Chinese medicinal toxicity absorbing ointment and preparation method thereof |
| 01/09/2013 | CN102861212A Ointment for treating corns |
| 01/09/2013 | CN102861209A Composite aloe medicine liquid |
| 01/09/2013 | CN102861206A Sterilizing and disinfecting aerosol for skin mucous membrane and preparation method thereof |
| 01/09/2013 | CN102861184A Traditional Chinese medicine for treating vulvar leukoplakia and preparation method thereof |
| 01/09/2013 | CN102861182A Decoction medicine for treating chronic urticaria |
| 01/09/2013 | CN102861165A Traditional Chinese medicine preparation for treating lupus erythematosus |
| 01/09/2013 | CN102861164A Chinese medicine composition for controlling radiation, its preparation method and application |
| 01/09/2013 | CN102861161A Method for preparing traditional Chinese medicine wet tissue for treating scale keratosis type tinea manus and tinea pedis |
| 01/09/2013 | CN102861155A Cream for treating psoriasis |
| 01/09/2013 | CN102861151A Traditional Chinese medicine compound for treating bedsores |
| 01/09/2013 | CN102861150A Chinese medicine powder for treating burn and scald and anabrosis |
| 01/09/2013 | CN102861128A Application of effective site of salvianolic acids to preparation of preparations for treating skin diseases |
| 01/09/2013 | CN102861123A Traditional Chinese medicine extract with effect on promoting angiogenesis as well as preparation method and application thereof |
| 01/09/2013 | CN102861101A Drug for preventing and curing electromagnetic radiation injury |
| 01/09/2013 | CN102861039A Medicinal formulation for treating beriberi |
| 01/09/2013 | CN102861038A Pharmaceutical formulation for treating psoriasis |
| 01/09/2013 | CN102860988A Chymotrypsin composition freeze-dried powder and preparation method thereof |
| 01/09/2013 | CN102860928A Itching-relieving bath lotion |
| 01/09/2013 | CN102860925A Application of theaflavin to preparation of tyrosinase inhibitor |
| 01/09/2013 | CN102302605B Angelica dahurica, goldthread and Chinese angelica powder for cracked nipple |
| 01/09/2013 | CN102293931B Traditional Chinese medicinal composition, clinical preparation and preparation methods thereof |
| 01/09/2013 | CN102133245B Brucea javanica oil obtained by reducing content of protein, and medicine composite and preparation method thereof |
| 01/09/2013 | CN102040643B Ciclesonide nitrate derivative |
| 01/09/2013 | CN101935349B Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/09/2013 | CN101816722B Wash-free antipruritic antibacterial gel with Chinese medicament components and preparation method thereof |
| 01/09/2013 | CN101757035B Preparation method of stable nanometer pearl dispersion liquid |
| 01/09/2013 | CN101491485B Skin external composition containing silybin glycoside |
| 01/09/2013 | CN101431997B Melatonin and immunostimulating substance-based compositions |
| 01/08/2013 | US8349896 Aspirin-triggered lipid mediators |
| 01/08/2013 | US8349803 Use of an active principle from flax for use in a composition for activating cytochrome c |
| 01/08/2013 | US8349331 Anti-interferon-α antibodies |
| 01/08/2013 | US8349307 Polymer conjugates of opioid antagonists |
| 01/08/2013 | CA2723848C Method of making salmon egg cytoplasmic extracts and use for increasing collagen production in skin |
| 01/08/2013 | CA2611435C Novel triterpenic acid derivative and preparation for external application for skin comprising the same |
| 01/08/2013 | CA2559377C Derivatives of genkwanin and sakuranetin, cosmetic and therapeutic use thereof and preparation method of same |
| 01/08/2013 | CA2510337C Topoisomerase-targeting agents |
| 01/08/2013 | CA2490121C Modified phospholipids |
| 01/08/2013 | CA2485081C Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2449910C Use of glycoprotein for the treatment and re-epithelialisation of wounds |
| 01/08/2013 | CA2323451C Skin conditioner |
| 01/03/2013 | WO2013003697A1 Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
| 01/03/2013 | WO2013003689A2 Compositions containing nitro fatty acids |
| 01/03/2013 | WO2013003356A1 Compositions, uses, and preparation of platelet lysates |
| 01/03/2013 | WO2013003307A1 2-methylene-(22e)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
| 01/03/2013 | WO2013003236A1 Retinoid topical compositions and methods for treating skin conditions |
| 01/03/2013 | WO2013003045A2 Procoagulant peptides and their derivatives and uses therefor |
| 01/03/2013 | WO2013002365A1 Antipruritic agent |
| 01/03/2013 | WO2013002364A1 Crystals of glycine derivative and pharmaceutical use thereof |
| 01/03/2013 | WO2013002331A1 Pharmaceutical preparation integrated with microneedles for skin treatment |
| 01/03/2013 | WO2013002248A1 Phosphoric acid ester derivative |
| 01/03/2013 | WO2013002196A1 Novel pharmaceutical composition |
| 01/03/2013 | WO2013001890A1 Soyasapogenol composition |
| 01/03/2013 | WO2013001819A1 SOLUBLE INTEGRIN α4 MUTANT |
| 01/03/2013 | WO2013001605A1 Composition for producing carbon dioxide |
| 01/03/2013 | WO2013001294A1 Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders |
| 01/03/2013 | WO2013001030A1 Oxazetidine derivatives, process for preparing them and use thereof in human medicine and in cosmetics |
| 01/03/2013 | WO2013000895A1 Dha and epa in the reduction of oxidative stress |
| 01/03/2013 | WO2013000406A1 Benzocycloheptanethiophene derivatives for anti-allergic reactions |
| 01/03/2013 | WO2013000382A1 Fatty acid composition and plant extract and pharmaceutical preparation and application thereof |
| 01/03/2013 | WO2013000267A1 Azole heterocyclic compound, preparation method, pharmaceutical composition and use |
| 01/03/2013 | WO2012152940A3 Small molecule inhibitors of trpa1 |
| 01/03/2013 | WO2012135337A3 Topical skin care formulations comprising plant extracts |
| 01/03/2013 | WO2012098546A3 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
| 01/03/2013 | WO2009093144A3 Photodynamic therapy for the treatment of sebaceous gland disorders |
| 01/03/2013 | US20130006350 Drug-delivery endovascular stent and method for treating restenosis |
| 01/03/2013 | US20130005824 Treatment of ischemic tissue |
| 01/03/2013 | US20130005803 Use of compounds in the treatment or prevention of skin disorders |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005774 Topical foam composition |
| 01/03/2013 | US20130005766 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 01/03/2013 | US20130005741 Substituted pyrimidine as a prostaglandin d2 receptor antagonist |
| 01/03/2013 | US20130005731 Crystalline forms of neurotrophin mimetic compounds and their salts |
| 01/03/2013 | US20130005728 Substituted pyrimidines as prostaglandin d2 receptor antagonists |
| 01/03/2013 | US20130005727 Quinazoline derivatives |
| 01/03/2013 | US20130005724 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof |